FDA ReviewedUpdated May 20, 2026

Zepbound Guide

Zepbound is the brand-name formulation of tirzepatide 2.5–15mg specifically FDA-approved for chronic weight management, launched by Eli Lilly in late 2023. It is chemically identical to Mounjaro but approved specifically for obesity treatment, making it eligible for different insurance coverage pathways and savings programs.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

At a Glance

Generic NameTirzepatide
Brand NamesZepbound
FDA StatusFDA-approved for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related comorbidity (November 2023)[1]
Approval DateNovember 8, 2023[1]

How Zepbound Works

Zepbound works through tirzepatide's dual GIP/GLP-1 mechanism to reduce appetite through both central brain signals and peripheral metabolic effects. GLP-1 activation creates feelings of fullness and slows digestion; GIP activation may additionally enhance fat metabolism and energy expenditure. This twin-hormone approach produces more weight loss than any single-pathway agent.[2]

Dosing Schedule

Zepbound uses a gradual dose escalation to minimize side effects. Always follow your prescriber's guidance and the current FDA label[1].

Weeks 1–42.5mg/week
Weeks 5–85mg/week
Weeks 9–127.5mg/week
Weeks 13–1610mg/week
Weeks 17–2012.5mg/week
Week 21+15mg/week (maintenance)

Side Effects

Common: nausea (31%), diarrhea (23%), vomiting (13%), constipation (12%), abdominal pain (9%), injection site redness. Nausea is most common during dose escalation and typically resolves within a month of each new dose. Serious (rare): pancreatitis, cholelithiasis (gallstones), suicidal ideation monitoring recommended, thyroid tumor risk noted in animal models.[1][2]

This is not a complete list. Consult your healthcare provider or prescriber for full safety information. The complete adverse reaction profile is published in the current FDA prescribing information[1].

Clinical Trial Results

In the SURMOUNT-1 trial, Zepbound (tirzepatide 15mg) produced an average weight loss of 22.5% (about 52 lbs) over 72 weeks — the highest of any anti-obesity medication ever studied. At 10mg, participants lost 21.4%; at 5mg, they lost 15.0%. 91% of participants lost at least 5% of body weight at the 15mg dose.[2][3]

Source: Published clinical trial data (STEP / SURMOUNT trial series) — see the Sources panel below for full citations.

Where to Get Zepbound

These telehealth providers offer access to tirzepatide or compounded equivalents with online consultations and home delivery.

8.4/ 10

GoodRx

Best for: self-pay brand-name Foundayo and Zepbound KwikPen at retail pharmacies

★★★★☆4.2

Editorial score · methodology

$149/mo
BrandOrforglipronTirzepatide
Get StartedRead full GoodRx review →
7.6/ 10

Vaylen

Best for: GLP-1-focused care with oral and injectable options across all 50 states

★★★★☆3.8

Editorial score · methodology

$179/mo
CompoundedSemaglutideTirzepatideLegitScript Verified
Get StartedRead full Vaylen review →
7.5/ 10

Effecty

Best for: nationwide compounded semaglutide with brand-name fallback

★★★★☆3.8

Editorial score · methodology

$160/mo
CompoundedSemaglutideTirzepatideLegitScript Verified
Get StartedRead full Effecty review →
7.4/ 10

Navio MD

Best for: compounded tirzepatide with brand-name fallback across 48 states

★★★★☆3.7

Editorial score · methodology

$247/mo
CompoundedTirzepatideSemaglutideLegitScript Verified
Get StartedRead full Navio MD review →
7.4/ 10

Alloy

Best for: women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directory

★★★★☆3.7

Editorial score · methodology

$80/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Alloy review →
7.3/ 10

altRX

Best for: Buyers who want the broadest possible brand-name FDA-approved GLP-1 access on a single platform — altRX is the only provider in the WLR directory offering all four (Mounjaro / Ozempic / Wegovy / Zepbound) alongside compounded options. Strong fit for patients who may switch between compounded and brand-name depending on response, supply, or insurance situation.

★★★★☆3.7

Editorial score · methodology

$149/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full altRX review →

Cost Comparison

Starting prices for compounded GLP-1 medications from top providers, sorted cheapest first. Compounded tirzepatide from licensed 503A and 503B pharmacies is legal under federal compounding law[4], with additional tolerances historically allowed while the molecule has appeared on the FDA Drug Shortage List[5]. Both compounded and brand-name prescriptions are generally FSA/HSA eligible under IRS Publication 502[6]. Prices may vary based on dose and promo availability.

ProviderStarting Price
GoodRx$299/moVisit
Alloy$349/moVisit
Vaylen$1086/moVisit
altRX$1249/moVisit
Navio MD$1249/moVisit
Effecty$1300/moVisit
HeliMeds$1396/moVisit

Related Research on Zepbound

Deep-dive articles from our research desk with primary-source trial data, FDA label verification, and editorial analysis.

Sauna vs Steam Room for Weight Loss: Honest Evidence Review
The honest answer is neither. Both produce ~0.5-1 kg of transient water-weight loss per 20-30 min session that returns within 24 h of rehydration. Real cardiovascular and recovery benefits exist; fat-loss benefits do not. GLP-1 dehydration risk is the load-bearing safety concern.
12 min read9 citations
How to Break a Weight-Loss Plateau: Honest Evidence Review
Weight-loss plateaus are predictable physiology — adaptive thermogenesis drops REE 15-20% below predicted and NEAT declines unconsciously. Six evidence-graded interventions (diet break, protein, resistance training, sleep, TDEE math, GLP-1 dose change) break most in 2-4 weeks.
11 min read11 citations
How Quickly Does Tirzepatide Work for Weight Loss? Honest Evidence Review
Tirzepatide produces appetite suppression within 1-7 days and first scale movement by week 2-4. SURMOUNT-1 reached 5% TBWL by week 12, 10% by week 24, and -20.9% peak at 72 weeks on the 15 mg dose.
9 min read9 citations
Does Anthem Cover Zepbound for Weight Loss? Honest Evidence Review
Yes on most Anthem commercial fully-insured plans with prior authorization (BMI ≥30, or ≥27 + comorbidity, plus a 3-6 month lifestyle program). Self-funded employer ASO plans may exclude weight-loss meds entirely. Medicare Advantage covers Zepbound only for the FDA-approved sleep apnea indication, not weight loss. Sourced to Anthem CC-0188, the FDA Zepbound label, SS Act §1860D-2(e)(2)(A), and the CMS Medicare GLP-1 Bridge.
10 min read11 citations
When To Drink Protein Shakes For Weight Loss? Honest Evidence Review
Timing is largely overrated. Schoenfeld 2013 meta-analysis (20 studies, 478 subjects): no timing effect on muscle outcomes when daily protein matched. Total daily dose dominates; breakfast and post-workout are the best satiety + muscle placements.
10 min read10 citations
Do Oranges Help With Weight Loss? Honest Evidence Review
Modestly yes — whole oranges (~62 kcal, 3.1 g fiber, 87% water per USDA FDC 169097) beat orange juice by a wide margin. Bertoia 2015 cohort: citrus -0.27 lb/4 yr per daily serving. Muraki 2013 BMJ: 100% OJ tied to higher T2D risk (HR 1.08) while whole fruit was protective.
9 min read12 citations

Frequently Asked Questions

Sources & methodology — as of May 2026
  1. 1.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  2. 2.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  3. 3.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
  4. 4.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  5. 5.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  6. 6.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.

Glossary references

Key terms in this article, linked to their canonical definitions.